This inventor holds 1 USPTO granted patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Shicong Liu: Innovator in Cancer Treatment
Introduction
Shicong Liu is a prominent inventor based in Shandong, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies.
Latest Patents
Shicong Liu holds a patent for an "Antibody against claudin 18A2 and use thereof." This patent includes an anti-CLDN18.2 antibody or an antigen-binding fragment thereof, along with a derivative comprising said antibody or antigen-binding fragment. The pharmaceutical composition and related uses of this antibody are aimed at treating, diagnosing, and detecting cancers. He has 1 patent to his name.
Career Highlights
Liu is associated with Qilu Pharmaceutical Co., Ltd., where he continues to work on groundbreaking research in the pharmaceutical industry. His work focuses on developing effective treatments for cancer, showcasing his commitment to improving patient outcomes.
Collaborations
Shicong Liu collaborates with talented individuals in his field, including Yingying Yang and Gao Li. Their combined expertise contributes to the advancement of innovative solutions in cancer therapy.
Conclusion
Shicong Liu's contributions to cancer treatment through his patented innovations highlight his role as a key figure in the pharmaceutical industry. His work continues to inspire advancements in medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile